ARCHIVES

Research Program For Biological Response Modifiers Outlined By DCT board Subcommittee

This article is from The Cancer Letter archive.

Vol. 05 No. 46 | November 16, 1979

Download PDF Visit The Full Archive

Related Articles

In Brief: Kenneth Olden Named Director Of Howard Cancer Center; Calhoon Sparked AMA On Cigarette Ads

February 21, 1986

NCI Staff Discusses New Guidelines for Core Grant Reviews, Comprehensiveness

July 24, 1992

Revlimid Also Demonstrates Response in Mantle Cell

July 29, 2011

$5 Million Lift Raises Payline From 180 to 185

May 21, 1982

Gene Delivery System Targets Tumor Blood Vessels In Dogs

March 27, 2009

Group chairmen Advises 7 Trials For Priority Status

June 14, 1991